DarioHealth jumps as B2B segment drives Q3 revenue beat

DarioHealth

15/11/2022 16:54

** Shares of DarioHealth Corp  DRIO.O  jump 28.1% to $5.02 
    ** DRIO will see its best day in more than 2 years, if gains
hold 
    ** Digital therapeutics co late Monday reported Q3 revenue
of $6.61 million, above estimates of $6.23 million - Refinitiv
IBES data 
    ** Revenue beat was driven by growth in its
business-to-business (B2B) segment, as it transitions to that
model from a direct-to-consumer business - co
    ** DRIO says it has signed 85 B2B contracts with total value
exceeding $61 million annually and maintained its goal to hit
100 contracts by year end 
    ** Despite session gains, stock down ~61% YTD 
 (Reporting by Sriparna Roy)
 ((Sriparna.roy@thomsonreuters.com))